258 related articles for article (PubMed ID: 17584767)
1. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.
Demura M; Martin RM; Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Mendonca BB; Hanaki K; Kanzaki S; Rhoads DB; Misra M; Bulun SE
Hum Mol Genet; 2007 Nov; 16(21):2529-41. PubMed ID: 17584767
[TBL] [Abstract][Full Text] [Related]
2. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.
Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Bulun SE
N Engl J Med; 2003 May; 348(19):1855-65. PubMed ID: 12736278
[TBL] [Abstract][Full Text] [Related]
3. Organization of the human aromatase p450 (CYP19) gene.
Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
[TBL] [Abstract][Full Text] [Related]
4. Different promoter usage for CYP19 gene expression in buffalo ovary and placenta.
Sharma D; Ghai S; Singh D
Gen Comp Endocrinol; 2009 Jul; 162(3):319-28. PubMed ID: 19375426
[TBL] [Abstract][Full Text] [Related]
5. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.
Bulun SE; Lin Z; Imir G; Amin S; Demura M; Yilmaz B; Martin R; Utsunomiya H; Thung S; Gurates B; Tamura M; Langoi D; Deb S
Pharmacol Rev; 2005 Sep; 57(3):359-83. PubMed ID: 16109840
[TBL] [Abstract][Full Text] [Related]
6. The promoter(s) of the aromatase gene in male testicular cells.
Carreau S; Bourguiba S; Lambard S; Silandre D; Delalande C
Reprod Biol; 2004 Mar; 4(1):23-34. PubMed ID: 15094793
[TBL] [Abstract][Full Text] [Related]
7. Novel promoter I.8 and promoter usage in the CYP19 (aromatase) gene.
Demura M; Reierstad S; Innes JE; Bulun SE
Reprod Sci; 2008 Dec; 15(10):1044-53. PubMed ID: 18955734
[TBL] [Abstract][Full Text] [Related]
8. Three promoters PII, PI.f, and PI.tr direct the expression of aromatase (cyp19) gene in male rat germ cells.
Silandre D; Delalande C; Durand P; Carreau S
J Mol Endocrinol; 2007 Aug; 39(2):169-81. PubMed ID: 17693615
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of aromatase in breast cancer tissues.
Harada N
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):175-84. PubMed ID: 9365188
[TBL] [Abstract][Full Text] [Related]
10. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
11. A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome.
Tiulpakov A; Kalintchenko N; Semitcheva T; Polyakov A; Dedov I; Sverdlova P; Kolesnikova G; Peterkova V; Rubtsov P
J Clin Endocrinol Metab; 2005 Jul; 90(7):4184-90. PubMed ID: 15811932
[TBL] [Abstract][Full Text] [Related]
12. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
13. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.
Bulun SE; Sebastian S; Takayama K; Suzuki T; Sasano H; Shozu M
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):219-24. PubMed ID: 14623514
[TBL] [Abstract][Full Text] [Related]
14. Aromatase expression in the human temporal cortex.
Yague JG; Muñoz A; de Monasterio-Schrader P; Defelipe J; Garcia-Segura LM; Azcoitia I
Neuroscience; 2006; 138(2):389-401. PubMed ID: 16426763
[TBL] [Abstract][Full Text] [Related]
15. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
16. Aromatase expression in health and disease.
Simpson ER; Zhao Y; Agarwal VR; Michael MD; Bulun SE; Hinshelwood MM; Graham-Lorence S; Sun T; Fisher CR; Qin K; Mendelson CR
Recent Prog Horm Res; 1997; 52():185-213; discussion 213-4. PubMed ID: 9238853
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a region upstream of exon I.1 of the human CYP19 (aromatase) gene that mediates regulation by retinoids in human choriocarcinoma cells.
Sun T; Zhao Y; Mangelsdorf DJ; Simpson ER
Endocrinology; 1998 Apr; 139(4):1684-91. PubMed ID: 9528950
[TBL] [Abstract][Full Text] [Related]
18. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation of placenta-specific Cyp19 promoters of cattle and sheep.
Vanselow J; Selimyan R; Fürbass R
Exp Clin Endocrinol Diabetes; 2008 Jul; 116(7):437-42. PubMed ID: 18523913
[TBL] [Abstract][Full Text] [Related]
20. Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants.
Fukami M; Shozu M; Soneda S; Kato F; Inagaki A; Takagi H; Hanaki K; Kanzaki S; Ohyama K; Sano T; Nishigaki T; Yokoya S; Binder G; Horikawa R; Ogata T
J Clin Endocrinol Metab; 2011 Jun; 96(6):E1035-43. PubMed ID: 21470988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
